Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Biology Professor Develops Medicine for Celiac Disease in Tampere – “the First One Will Earn Billions”

Summary by Tärkeimmät Talousuutiset | Kauppalehti…
Professor Jorma Isola's highly profitable Jilab Oy is developing the world's first medicine for celiac disease with large pharmaceutical companies.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Tärkeimmät talousuutiset | Kauppalehti…Tärkeimmät talousuutiset | Kauppalehti…

Biology Professor Develops Medicine for Celiac Disease in Tampere – “the First One Will Earn Billions”

Professor Jorma Isola's highly profitable Jilab Oy is developing the world's first medicine for celiac disease with large pharmaceutical companies.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Tärkeimmät talousuutiset | Kauppalehti… broke the news in on Thursday, October 23, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Tampere icon

Tampere

News
For You
SearchBlindspotLocal